GlassScriptPhysician profile
Michael Anthony Errico
NPI 1770897522
$531.87
in general payments reported to CMS, 2019-2025
12 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $57.49 · 2022: $108 · 2024: $20.34 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $154.06 | 2022-2025 | |
| Portola Pharmaceuticals, LLC | $81.18 | 2019-2020 | |
| Ambu INC. | $71.32 | 2025 | |
| Amgen INC. | $58.91 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $33.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.59 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.54 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.34 | 2024 | Terlivaz |
| Mallinckrodt Enterprises LLC | $17.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.55 | 2019 | |
| United Therapeutics Corporation | $14.15 | 2020 | |
| Avanir Pharmaceuticals, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Errico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.